FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely pharmaceutical industry, and concerns a composition for preventing or treating a menopause symptom, containing cinnamylic acid, shanzhiside methyl ester or a mixture thereof as an active ingredient.
EFFECT: preparing the pharmaceutical composition for preventing or treating the menopause symptom.
3 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
METHOD OF TREATING GENITOURINARY SYNDROME IN MENOPAUSAL WOMEN BY MEANS OF PLACENTAL THERAPY | 2019 |
|
RU2710015C1 |
METHOD FOR TREATING CLIMACTERIC DISORDERS IN WOMEN EITHER DURING OR AFTER MENOPAUSE | 2001 |
|
RU2268035C2 |
METHOD FOR INHIBITION OF ATROPHY OR TREATMENT OR PROPHYLAXIS OF SYMPTOMS RELATES TO ATROPHY IN WOMEN | 2003 |
|
RU2317816C2 |
METHOD FOR ENHANCING OF TESTOSTERONE AND ANALOGOUS STEROID LEVELS IN FEMALES | 2001 |
|
RU2286787C2 |
COMPOSITIONS, APPLICATORS, SETS WITH CONJUGATED ESTROGEN AND METHODS OF THEIR OBTAINING AND APPLICATION | 2006 |
|
RU2420292C2 |
DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
SCHEME OF ESTROGEN REPLENISHMENT | 2003 |
|
RU2340345C2 |
DROSPYRENON FOR REPLACEMENT HORMONOTHERAPY | 2001 |
|
RU2275198C2 |
METHOD FOR CORRECTION OF VEGETATIVE SYMPTOM OF CLIMACTERIC SYNDROME IN WOMEN WITH ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2005 |
|
RU2282445C1 |
Authors
Dates
2013-09-10—Published
2008-12-26—Filed